Research map: Extranodal involvement defines distinct immune-molecular phenotypes and clinical outcomes in diffuse large b-cell lymphoma

Back to the article

Papers in this map

  1. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing · Yoav Benjamini · 1995 · 112507 citations · Cited by this paper
  2. LRP8 drives cervical cancer lymph node metastasis by promoting epithelial-mesenchymal transition and VEGF-C secretion · 2026 · Related
  3. Trimmomatic: a flexible trimmer for Illumina sequence data · Anthony Bolger · 2014 · 71940 citations · Cited by this paper
  4. Global trends in the burden of inflammatory bowel disease from 1990 to 2021: socioeconomic and sex-specific disparities with exploratory mendelian randomization analyses · 2026 · Related
  5. Fast and accurate short read alignment with Burrows–Wheeler transform · Heng Li · 2009 · 64044 citations · Cited by this paper
  6. Pan-cancer analysis identifies KANSL2 as a cell-cycle–associated regulator of tumor progression and immunity in liver hepatocellular carcinoma · 2026 · Related
  7. limma powers differential expression analyses for RNA-sequencing and microarray studies · Matthew E. Ritchie · 2015 · 44581 citations · Cited by this paper
  8. Serum TIMP-1 shows a potential association with metastatic disease in patients with pancreatic cancer: a pilot analysis without a healthy control cohort · 2026 · Related
  9. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters · Guangchuang Yu · 2012 · 39746 citations · Cited by this paper
  10. Integrated bioinformatic evaluation unveils a cellular senescence gene signature as a poor prognostic factor in hepatocellular carcinoma · 2026 · Related
  11. WGCNA: an R package for weighted correlation network analysis · Peter Langfelder · 2008 · 30183 citations · Cited by this paper
  12. Population-specific association and risk discrimination utility of the cardiometabolic index for prevalent hypertension–diabetes comorbidity: insights from CHARLS and NHANES · 2026 · Related
  13. Twelve years of SAMtools and BCFtools · Petr Danecek · 2021 · 17144 citations · Cited by this paper
  14. Beyond polarization: a receptor-centered framework for macrophage function and therapy in skin diseases · 2026 · Related
  15. GSVA: gene set variation analysis for microarray and RNA-Seq data · Sonja Hänzelmann · 2013 · 17099 citations · Cited by this paper
  16. Dissecting PCD-driven molecular landscapes in AML: a multi-omic framework for prognostication and therapeutic targeting · 2026 · Related
  17. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling · Ash A. Alizadeh · 2000 · 10026 citations · Cited by this paper
  18. Thromboembolic risk in subcutaneous versus intravenous immunoglobulin therapy: a systematic review and narrative meta-synthesis · 2026 · Related
  19. The Ensembl Variant Effect Predictor · William M. McLaren · 2016 · 9004 citations · Cited by this paper
  20. The 2016 revision of the World Health Organization classification of lymphoid neoplasms · Steven H. Swerdlow · 2016 · 7946 citations · Cited by this paper
  21. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification · Bruce D. Cheson · 2014 · 5729 citations · Cited by this paper
  22. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma · Bertrand Coiffier · 2002 · 5633 citations · Cited by this paper
  23. Maftools: efficient and comprehensive analysis of somatic variants in cancer · Anand Mayakonda · 2018 · 5596 citations · Cited by this paper
  24. Determining cell type abundance and expression from bulk tissues with digital cytometry · Aaron M. Newman · 2019 · 5059 citations · Cited by this paper
  25. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma · The International Non-Hodgkin's Lymphoma Prognostic Factors Project · 1993 · 5010 citations · Cited by this paper
  26. xCell: digitally portraying the tissue cellular heterogeneity landscape · Dvir Aran · 2017 · 4826 citations · Cited by this paper
  27. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma · Roland P. H. Schmitz · 2018 · 2327 citations · Cited by this paper
  28. Diffuse Large B-Cell Lymphoma · Laurie Helen Sehn · 2021 · 1211 citations · Cited by this paper
  29. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications · George W. Wright · 2020 · 1199 citations · Cited by this paper
  30. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma · Anupama Reddy · 2017 · 1155 citations · Cited by this paper
  31. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era · Zheng Zhou · 2013 · 968 citations · Cited by this paper
  32. Diffuse large B-cell lymphoma · Shaoying Li · 2017 · 661 citations · Cited by this paper
  33. Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma · Madhavi Challa-Malladi · 2011 · 450 citations · Cited by this paper
  34. Genetics of diffuse large B-cell lymphoma · Laura Pasqualucci · 2018 · 304 citations · Cited by this paper
  35. Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures · Nikita Kotlov · 2021 · 267 citations · Cited by this paper
  36. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence · Thomas A. Ollila · 2018 · 193 citations · Cited by this paper
  37. Sites of extranodal involvement are prognostic in patients with diffuse large B‐cell lymphoma in the rituximab era: An analysis of the Surveillance, Epidemiology and End Results database · Jorge Julio Castillo · 2013 · 180 citations · Cited by this paper
  38. Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma · Marco Fangazio · 2021 · 99 citations · Cited by this paper
  39. Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era · Sabela Bobillo · 2020 · 64 citations · Cited by this paper

Source: OpenAlex (CC0)